$292 Million is the total value of INTERWEST VENTURE MANAGEMENT CO's 11 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
TSRO | TESARO INC | $167,541,000 | -35.8% | 2,021,738 | 0.0% | 57.29% | -15.7% | |
GKOS | GLAUKOS CORP | $26,121,000 | -22.3% | 1,018,362 | 0.0% | 8.93% | +2.1% | |
EIGR | EIGER BIOPHARMACEUTICALS INC | $22,314,000 | +26.8% | 1,599,592 | 0.0% | 7.63% | +66.5% | |
MGNX | MACROGENICS INC | $20,412,000 | +2.8% | 1,074,316 | 0.0% | 6.98% | +35.0% | |
OBLN | OBALON THERAPEUTICS INC | $16,217,000 | -30.6% | 2,453,338 | 0.0% | 5.54% | -8.9% | |
CDTX | CIDARA THERAPEUTICS INC | $9,226,000 | -16.1% | 1,356,813 | 0.0% | 3.16% | +10.2% | |
IVTY | INVUITY INC | $6,698,000 | -30.3% | 1,080,272 | 0.0% | 2.29% | -8.5% | |
AGTC | APPLIED GENETIC TECHNOL CORP | $5,241,000 | -8.9% | 1,455,904 | 0.0% | 1.79% | +19.7% | |
KALV | KALVISTA PHARMACEUTICALS INC | $3,217,000 | +44.8% | 329,942 | 0.0% | 1.10% | +90.3% | |
XENE | XENON PHARMACEUTICALS INC | $23,000 | -4.2% | 8,293 | 0.0% | 0.01% | +33.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-01-10
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
GLAUKOS CORP | 28 | Q3 2023 | 33.0% |
EIGER BIOPHARMACEUTICALS INC | 24 | Q3 2022 | 17.7% |
APPLIED GENETIC TECHNOL CORP | 24 | Q3 2022 | 6.7% |
XENON PHARMACEUTICALS INC | 20 | Q3 2021 | 0.6% |
CIDARA THERAPEUTICS INC | 19 | Q2 2021 | 4.5% |
THE REALREAL | 18 | Q3 2023 | 62.6% |
KALVISTA PHARMACEUTICALS INC | 17 | Q4 2020 | 10.8% |
DARE BIOSCIENCE INC | 16 | Q3 2023 | 0.3% |
MACROGENICS INC | 14 | Q1 2020 | 19.2% |
PMV PHARMACEUTICALS INC | 13 | Q3 2023 | 67.5% |
View INTERWEST VENTURE MANAGEMENT CO's complete holdings history.
Latest filings
Type | Filed |
---|---|
144 | 2024-02-27 |
13F-HR | 2023-10-20 |
13F-HR | 2023-07-21 |
13F-HR | 2023-04-27 |
13F-HR | 2023-01-31 |
13F-HR | 2022-10-25 |
13F-HR | 2022-08-02 |
13F-HR | 2022-04-13 |
13F-HR | 2022-01-25 |
13F-HR | 2021-10-19 |
View INTERWEST VENTURE MANAGEMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.